CNBC just did a documentary on AEMD and the power of research reports sites, and new technology being used to scan the markets via research reports. Savvy investors that follow research reports are often statistically ahead of the street by DAYS, this can often translate into millions in potential profits. They mentioned that flash market research (google them ), a site I can vouch and have personally profited over $190k net profits, is now using this technology. This could change the markets for AEMD and all public companies!
At present, small molecule therapies are the most widely used approach in cancer treatments. In many cases they are rendered ineffective due to resistance or to debilitating side effects, leaving the oncology landscape extremely challenged to develop new, innovative approaches. Immunotherapy, which uses the body's immune system to fight tumors, has delivered some very promising advanced data in the last decade, with Dendreon Corporation (DNDN) becoming the first immunotherapy to garner FDA approval in April 2010 as a new treatment for certain men with advanced prostate cancer.